•  
  •  
  •  
  •  

2026-02-07 01:29:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Fusion Finance Q3 FY26: Disbursements Surge 23% QoQ to ₹1,594 Cr, PAT Swings to ₹14 Cr Profit
  • Nifty Recovers 200 Points to End the Session Near Day high
  • Gateway Distriparks Q3 FY26: Revenue Soars 39% to ₹566 Cr, PAT Up 4% - Declares ₹2 Special Dividend on Debt-Free Milestone
  • Mamaearth Onboards Sreeleela as Hair Care Category Brand Ambassador; Unveils Valentine's Day Film for Rosemary Anti-Hair Fall Shampoo
  • Wanbury Limited Q3 FY26: PAT Explodes 1,194% YoY to ₹15.8 Cr, Revenue Up 22%

Keywords Selected:  APIs

Stock Report

  • MIC Electronics Ltd receives first order of PAPIS
  • Sigachi Industries achieves Key R&D Milestone in Cystic Fibrosis APIs
  • Apis India Ltd allots 13,22,41,824 bonus equity shares
  • Kotak Neo introduces zero-brokerage, zero-fee TRADE APIs for retail traders
  • Apis India Limited recommends 24:1 bonus issue
  • Nectar Lifesciences announces strategic sale of API and Formulations Business to Ceph Lifesciences for ₹1,270 Crores
  • Gland Pharma Ltd receives EIR from US FDA for JNPC Facility, Visakhapatnam
  • USFDA issues Form 483 with 3 observations to Gland Pharma's Sterile APIs unit
  • MIC Electronics Ltd receives approval of CCA for GPS Location based Public Address & Passenger Information System
  • Alembic Pharmaceuticals Limited passes ANVISA, Brazil GMP audit for its API-II Facility at Panelav
  • Bajaj Healthcare Limited enters into CDMO contracts for 15 new APIs
  • Blue Dart Offers Cutting-Edge Digital Empowerment Solution for MSMEs and Large Enterprises
  • Bajaj Healthcare Ltd enters into definitive CDMO Agreement for 15 APIs with UK/EU Customers
  • Propelling the Revolution towards Organic, 'APIS INDIA LIMITED unveils its Organic Honey product in a gala ceremony'
  • Zydus Lifesciences Ltd receives 6 observations from USFDA for API site at Changodar
  • APIS India Ltd approves transfer of B2C Business Division to subsidiary through slump sale
  • Eiko LifeSciences acquires 25.01% stake in Reflux Pharmaceuticals Pvt Ltd
  • Apis India expands its Spread Category with the launch of Hazelnut Chocolate spread
  • Alembic Pharmaceuticals Ltd passes ANVISA, Brazil GMP audit for its API-III Facility at Karakhadi
  • Apis India Enters Spread Category with the launch of Peanut Butter
  • This Winter, Rejuvenate your soul with Apis India’s newest addition – Lemon Honey Green Tea
  • APIS India Ltd Q1 FY2023 consolidated profit at Rs. 1.77 crore
  • Bajaj Healthcare Ltd forays into the highly regulated - Opiate Processing Business for the Government of India
  • APIS India Ltd Q4 FY2022 consolidated profit rises to Rs. 5.14 crores

Latest Post

  • Fusion Finance Q3 FY26: Disbursements Surge 23% QoQ to ₹1,594 Cr, PAT Swings to ₹14 Cr Profit
  • Nifty Recovers 200 Points to End the Session Near Day high
  • Gateway Distriparks Q3 FY26: Revenue Soars 39% to ₹566 Cr, PAT Up 4% - Declares ₹2 Special Dividend on Debt-Free Milestone
  • Mamaearth Onboards Sreeleela as Hair Care Category Brand Ambassador; Unveils Valentine's Day Film for Rosemary Anti-Hair Fall Shampoo
  • Wanbury Limited Q3 FY26: PAT Explodes 1,194% YoY to ₹15.8 Cr, Revenue Up 22%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025